Basal Insulin Dosing in Type 2 Diabetes on Metformin
Start basal insulin at 10 units once daily OR 0.1-0.2 units/kg/day in patients with type 2 diabetes already taking metformin.
Initial Dosing Strategy
The most recent and authoritative guidelines provide clear starting doses:
- Fixed dose approach: Start with 10 units once daily 1, 2
- Weight-based approach: Start with 0.1-0.2 units/kg/day 1, 3, 2
The 2023 AACE guidelines refine this further based on baseline A1C 4:
- A1C <8%: Use 0.1-0.2 units/kg/day
- A1C ≥8%: Use 0.2-0.3 units/kg/day
The FDA-approved labeling for insulin glargine specifically states 0.2 units/kg or up to 10 units once daily for insulin-naive type 2 diabetes patients 2.
Insulin Selection
Prefer long-acting basal insulin analogs (glargine U-100, glargine U-300, degludec, or detemir) over NPH insulin to reduce hypoglycemia risk 1, 4, 3. While NPH may be more affordable, the newer analogs demonstrate superior safety profiles with less nocturnal hypoglycemia 1.
Titration Protocol
After initiation, titrate every 2-3 days based on fasting blood glucose 1, 4:
Increase dose when fasting glucose is:
- >180 mg/dL: Increase by 20% (or 4 units)
- 140-180 mg/dL: Increase by 10% (or 2 units)
- 110-139 mg/dL: Increase by 1 unit
Target fasting glucose: <110 mg/dL 4
Important caveat: Longer-acting insulins (glargine U-300, degludec) require slower titration every 3-5 days due to longer time to steady state 4.
Hypoglycemia Management
Reduce insulin dose when:
- Fasting glucose <70 mg/dL: Decrease by 10-20%
- Fasting glucose <40 mg/dL: Decrease by 20-40% 4
Concomitant Medications
Continue metformin when adding basal insulin 1, 3. This combination provides complementary mechanisms: metformin reduces hepatic glucose production and improves insulin sensitivity, while basal insulin directly addresses insulin deficiency.
Discontinue sulfonylureas when starting basal insulin to reduce hypoglycemia risk 4.
Common Pitfalls to Avoid
Underdosing at initiation: Starting too conservatively (e.g., 4-6 units) delays glycemic control. The evidence supports 10 units or weight-based dosing as safe and effective starting points 1, 2.
Inadequate titration: Many patients remain on subtherapeutic doses. Implement systematic titration protocols and empower patients to self-titrate based on home glucose monitoring 1, 3.
Overbasalization: If basal insulin doses exceed 0.5 units/kg/day without achieving A1C goals, consider adding GLP-1 receptor agonist or prandial insulin rather than continuing to increase basal insulin 1, 3.
Injection site issues: Rotate injection sites within the same region (abdomen, thigh, or deltoid) to prevent lipodystrophy, which can cause erratic insulin absorption 2.
When to Intensify Beyond Basal Insulin
If A1C remains above target despite optimized basal insulin (typically >0.5 units/kg/day with acceptable fasting glucose), add:
- GLP-1 receptor agonist (preferred for weight benefit and lower hypoglycemia risk) 3, OR
- Prandial insulin before meals 1, 3
The clinical reality is that basal insulin combined with metformin achieves A1C <7% in approximately 50% of patients 5. The remaining patients require treatment intensification, which should not be delayed due to therapeutic inertia.